Your browser doesn't support javascript.
loading
Regulatory role and translational potential of CCL11 in liver fibrosis.
Kong, Ming; Dong, Wenhui; Kang, Aoqi; Kuai, Yameng; Xu, Tongchang; Fan, Zhiwen; Shi, Longqing; Sun, Donglin; Lu, Yunjie; Li, Zilong; Xu, Yong.
Afiliação
  • Kong M; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Translational Medicine, and Center for Experimental Medicine, Department of Pathophysiology, Nanjing Medical University, Nanjing, China.
  • Dong W; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Translational Medicine, and Center for Experimental Medicine, Department of Pathophysiology, Nanjing Medical University, Nanjing, China.
  • Kang A; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Translational Medicine, and Center for Experimental Medicine, Department of Pathophysiology, Nanjing Medical University, Nanjing, China.
  • Kuai Y; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Translational Medicine, and Center for Experimental Medicine, Department of Pathophysiology, Nanjing Medical University, Nanjing, China.
  • Xu T; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Translational Medicine, and Center for Experimental Medicine, Department of Pathophysiology, Nanjing Medical University, Nanjing, China.
  • Fan Z; Department of Pathology, Nanjing Drum Tower Hospital Affiliated With Nanjing University, Nanjing, China.
  • Shi L; Department of Hepatobiliary Surgery, the First People's Hospital of Changzhou, The Third Hospital Affiliated With Soochow University, Changzhou, China.
  • Sun D; Department of Hepatobiliary Surgery, the First People's Hospital of Changzhou, The Third Hospital Affiliated With Soochow University, Changzhou, China.
  • Lu Y; Department of Hepatobiliary Surgery, the First People's Hospital of Changzhou, The Third Hospital Affiliated With Soochow University, Changzhou, China.
  • Li Z; State Key Laboratory of Natural Medicines, Department of Pharmacology, China Pharmaceutical University, Nanjing, China.
  • Xu Y; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Translational Medicine, and Center for Experimental Medicine, Department of Pathophysiology, Nanjing Medical University, Nanjing, China.
Hepatology ; 78(1): 120-135, 2023 07 01.
Article em En | MEDLINE | ID: mdl-36651177
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatócitos / Cirrose Hepática Limite: Animals Idioma: En Revista: Hepatology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatócitos / Cirrose Hepática Limite: Animals Idioma: En Revista: Hepatology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China